Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ionobell is a materials science and battery technology company that develops advanced silicon-based solutions for energy storage and life sciences. Headquartered in the BioCube life science incubator in San Jose, California, the company specializes in the production of porous nano-particle silicon, which serves as a high-capacity, "drop-in" replacement for graphite in lithium-ion battery anodes. Beyond its primary focus on the automotive and consumer electronics sectors, Ionobell markets its silicon materials for use in pharmaceutical drug delivery systems and agricultural applications. The company's technology enables a 50% increase in energy density and faster charging speeds while utilizing existing manufacturing infrastructure. Ionobell operates on a licensing model and has established partnerships with major automotive manufacturers and research institutions like Stanford University.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ionobell.